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A pilot study aimed to introduce intraoperative monitoring of liver surgery using transoesophageal echocardiography (TEE) is
described. A set of TEE measurements was established as a protocol, consisting of left atrial (LA) dimension at the aortic valve
plane; mitral velocity flow integral, calculation of stroke volume and cardiac output (CO); mitral annular plane systolic excursion;
finally, right atrial area. A total of 165 measurements (on 21 patients) were performed, 31 occurring during hypotension. The con-
clusions reached were during acute blood loss LA dimension changed earlier than CVP, and, in one patient, a dynamic left ventricu-
lar (LV) obstruction was observed; in 3 patients a transient LV systolic dysfunction was documented. The comparison between 39
CO paired measurements obtained by TEE and PiCCO2 revealed a statistically significant correlation (P < 0.001, r = 0.83). In this
pilot study TEE successfully answered the questions raised by the anesthesiologists. Larger cohort studies are needed to address
this issue.
1. Introduction
In major surgery haemodynamic complications are likely to
occur; hence for this reason monitoring is necessary to trace
physiological parameters. There are several commercially
available monitoring systems, but transoesophageal echocar-
diography (TOE)was not as extensively studied in noncar-
diac [1] as it was in cardiac surgery [2–5]. Due to its unique
ability for cardiac imaging, assessing left ventricular (LV)
function and right heart chambers dimensions, it is consid-
ered promising [5].
The questions faced by anaesthesiologists in noncardiac
surgery are quite diﬀerent from those in cardiac surgery,
where valvular diseases, prosthesis placement and compli-
cations are the most relevant. Questions on LV function or
acute change in volume status and hypotension are more
concerning in noncardiac surgery. Good candidates for such
monitoring are patients submitted to major surgery, espe-
cially those undergoing liver surgery or even transplantation
[6–8]. During this type of surgery, haemodynamic instability
can occur during liver manipulation or due to associated
blood loss.
In our centre, the usual means formonitoring include the
continuous monitoring of the central venous pressure (CVP)
and, in selected cases, the continuous monitoring of cardiac
output (CO) through the use of the PiCCO system. Pulmo-
nary artery catheters, used more often in the past, are now
seldom used. As resident anaesthesiologists felt an increasing
need for a more accurate monitoring, a pilot study aimed to
introduce intraoperative monitoring of liver surgery using
TOE was performed. This study was aimed to evaluate the
place of TOE for liver surgery monitoring and to compare
eﬃciency of TOE measurements with PVC and PiCCO to
diagnose hemodynamic instability causes. A set of TOE
measurements was established as a protocol, after previous
discussion with the anaesthesiology staﬀ about the required
information. A comparison between the information derived
from the monitoring devices used was also performed.
2. Material and Methods
2.1. Patients. This was a 1-year prospective study, which in-
cluded patients submitted to liver surgery and enrolled with-
out previous selection, although limited to the availability of
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the anesthesiologists (FP and AO), intensive care specialist
with expertise in the area (PM), and echocardiography
equipment. This pilot study was open with the anaesthesiol-
ogists being aware of TOE information. All data was digitally
recorded for later visualisation, if deemed necessary.
Patients were characterized by age, gender, and body sur-
face area. Main diagnoses (for surgical purposes) and comor-
bidities were also collected. The main demographic and
clinical characteristics of the enrolled patients are presented
in Table 1.
The study protocol was reviewed by the local Ethics
Board, and an informed statement was obtained previous to
surgery.
2.2. Methods. During liver surgery, hypotension and liver
manipulation (reported by the surgeons) were the most re-
garded situations. Hypotension was considered when mean
arterial blood pressure was 60mmHg or lower, and data was
thoroughly analysed. Blood loss was considered either by the
reports from the surgeons or by a decrease in haemoglobin
levels of more than 2 gr/dL. Other possible aetiologies were
evaluated according to the available monitoring devices.
Patients were anaesthetised using a general balanced an-
aesthesia, having been intubated after anaesthesia induction.
CVP monitoring was performed continuously using a
central venous line connected to a PhilipsM4monitor, where
the arterial pressure and heart rate were also registered. The
arterial pressure was monitored invasively using an arterial
catheter inserted into a radial or femoral artery. The invasive
CO, when used, was determined using a PiCCO 2 system, for
which a central venous line and a femoral arterial line were
inserted and then calibrated according to the manufacturer’s
instructions.
2.3. Echocardiography. The TOE monitoring was performed
using a Siemens ACCUSON X300 and a General Electric
LOGIC P6, both equipped with a multiplane transoesophag-
eal probe.
Before the study started, a consensus was established with
the anaesthesiologists to determine the information needed
for monitoring. The information considered necessary was
previous surgery knowledge of the heart anatomy and func-
tion; CO; left ventricular (LV) performance; data on volume
status; right heart chamber evaluation. Special concern was
addressed to the TOE parameters; they needed to be easily
obtained, not time consuming, in order to permit quick ther-
apeutic decisions. It was also established that intragastric
views should not be used so as to avoid interference with the
surgical field. The choice of invasive monitoring was carried
out by the anaesthesiologist’s judgement and independent of
study purposes.
After anaesthesia induction, a transoesophageal probe
was inserted and the first images obtained. A global exam-
ination was first performed and global and segmental wall
motion abnormalities were evaluated, as well as valvular re-
gurgitations. The following sets of measurements were cho-
sen in order to obtain the information previously required by
the anaesthesiologists. The CO was obtained through the
Table 1: Demographic and clinical characterization of studied
patients (n = 21).
Age (years, mean, and sd) 54.1 ± 17.6
Male (n) 12
Body surface area (m2, mean and sd) 1.73 ± 0.17
Liver resection due to metastatic disease (n) 14
Liver resection due to other diseases (n) 4
Liver transplant (n) 3
Past history:
Coronary artery disease 1
Hypertension 2
Diabetes mellitus 2
Other 1
mitral velocity time integral (VTI), measured as follows. First
the left ventricular influx by evaluation of the mitral E/A
ratio in the 4-chamber view was analysed. Secondly, left ven-
tricular CO was assessed by measuring the mitral VTI, calcu-
lating the stroke volume index (SVI) and multiplying it by
heart rate (Figure 1). Necessary information with regards to
the width of themitral valve orifice wasmeasured in the same
view (Figure 2). The LV function was assessed through the
external mitral annulus systolic excursion (MAPSE, consid-
ered the most feasible parameter compared to ejection frac-
tion and other volumetric parameters) obtained in the same
4-chamber view. At the aortic valve plane, during diastole
when the three aortic cuspids were visible, visible left atrium
(LA) area and dimension, obtained from the LA first echo to
aortic valve (Figure 3), were determined. Lastly, the assess-
ment of right heart chambers was performed; the probe was
repositioned for the assessment of the right atrium and ven-
tricle. The measurement of the right atrial area was empha-
sized (Figure 4). All TOE measurements were performed at
end-expiration, and other changes detected during TOEwere
registered. TOE evaluation was performed routinely every
15 minutes of surgery or whenever considered necessary if
hypotension, blood loss, or liver manipulation were report-
ed.
An LV systolic dysfunction was considered whenever
MAPSE was <15mm, and CO <2,4 L/m2. LA and RA dimen-
sions were considered the TOE surrogates for volume status
and preload determination and regarded as changes from the
previous measurements.
2.4. Statistical Analysis. All variables are presented as mean
and standard deviations. To compare continuous variables,
parametric and nonparametric statistical tests were used, cal-
culating the correlation index (r) and P value, which were
considered significant if <0.05. The statistical program used
was an SPSS for Windows, version 18.0 (SPSS Inc, Chica-
go, Illinois). Comparisons were made between data from
TOE and usual monitored parameters. The parameters com-
pared were CO analysis by PiCCO and TOE whenever availa-
ble and preload assessment comparing CVP with LA and RA
measurements, as well as its changes during acute phenom-
ena.
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Figure 1: Determination of the mitral VTI.
Figure 2: Determination of the mitral annulus diameter.
3. Results
Overall, 165 TEE dataset measurements were performed, and
in 5 patients a PiCCO2 system was present. Overall, 31 reg-
istries were performed during hypotension. Of these, 16 (5
patients) were due to hemorrhage, 9 (5 patients) without ob-
vious cause, and 6 (4 patients) due to liver manipulation.
In the haemorrhage evaluation the LA and RA dimen-
sions decreased in all patients, as well as CVP, but it occurred
simultaneously in only two occasions. In the remaining
measurements (n = 29), TOE modifications preceded CVP
changes by 10 to 15 minutes. In Table 2, and in Figure 5, a
graphic representing a registry during an acute blood loss
and changes in CVP and visible LA area and dimension is
presented. It was also observed that the LA dimension
decreased almost uniformly by nearly 20% (19.8% ± 0.9).
The comparative data of the parameters previous to haemor-
rhage and during haemorrhage is presented.
There were 6 cases of liver manipulation. In two episodes
hypotension occurred without changes in CVP. Interestingly,
LA and RA dimensions decreased during liver manipulation,
but CVP and CO remained unchanged. The comparative
data obtained previous to and during liver manipulation are
presented in Table 3.
In 9 cases (5 patients), a hypotensive episode was docu-
mented without blood loss. Within this group, in two cases a
typical change in volume status was detected by TOE, but
not by CVP; in one case, a decreased volume status was
Figure 3: Determination of visible LA area and dimension (distance
from the first echo from LA to aortic valve) in the aortic plane.
Figure 4: Determination of the right atrial area.
identified by both methods; in two cases there was no change
observed by the two methods; in three episodes (3 patients)
a systolic dysfunction was detected by TOE (decrease in
CO and MAPSE) in patients with previous normal LV con-
tractility. This LV dysfunction was transient and, due to glob-
al LV hypokinesia, the recovery was observed within a few
minutes. No apparent cause for this phenomenon was
detected.
Only one patient presented an LV dysfunction, detected
previous to surgery, suﬀering from ischemic heart disease.
During surgery, hypotension was detected during a massive
blood loss, and LV dysfunction exacerbated, along with
exacerbated wall motion abnormalities. Vasopressor and
inotropic support was started, some recovery of LV contrac-
tility was observed but the patient remained hypotensive.
This patient died in the early postoperative period in the
Intensive Care Unit.
Overall, TOE-derived CO varied more markedly than
PiCCO2-derived; the mitral E/A wave form changed during
anaesthesia induction and remained less than one during
most part of the surgery. The first obtained mean values for
this parameter were 0.99± 0.47 and for the remaining 0.83±
0.36 (P = 0.001). However no relevant information could
be obtained from this parameter during surgery, even during
hypotension/blood losses.
By linear regression analysis, considering CVP as a
dependent variable and LA dimension and RA area as in-
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Table 2: Comparison of hemodynamic and echocardiographical data in hypotension due to blood losses (16 sets of measurements in 5
patients).
Parameter Data before hypotension Data during hypotension P
HR (bpm) 71.7± 9.4 74 ± 11.8 ns
CVP (mmHg) 6.7± 1.9 5.2± 2.2 0.01
LA area (cm2) 9.1± 3.5 5.4± 2.2 0.001
LA dimension (mm) 28.5± 4.7 22.8± 4.3 0.001
RA area (cm2) 15.1 ± 2.4 13.8 ± 2.6 0.01
Mitral E/A 0.73± 0.33 0.76± 0.34 ns
PiCCO CO (mL/min) 4322 ± 452 3921 ± 404 0.001
TOE CO (L/min) 4571 ± 472 3622 ± 463 <0.001
MAPSE (mm) 16.2± 0.9 16.1± 1.3 ns
HR: heart rate, bpm: best per minute, CVP: central venous pressure, LA: left atrium, RA: right atrium, TOE: transoesophageal echocardiography, MAPSE:
mitral annulus systolic excursion, cm2: squared centimetres, mm: millimeters, and mL/min: mililiters per minute.
Table 3: Comparison of hemodynamic and echocardiographical data during liver manipulation (6 sets of measurements in 4 patients).
Parameter Data before liver manipulation Data during liver manipulation P
HR (bpm) 69 ± 7.6 72.2± 9.1 ns
CVP (mmHg) 6.1± 1.1 6.1± 1.8 ns
LA area (cm2) 9.9± 3.2 6.2± 3.4 0.003
LA dimension (mm) 28.4± 3.9 25.2± 4.1 0.005
RA area (cm2) 15.6 ± 2.2 15.3 ± 2 ns
Mitral E/A 0.77± 0.3 0.84± 0.39 ns
PiCCO CO (mL/min) 4020 ± 397 4150 ± 425 ns
TEE CO (L/min) 4286 ± 438 4481 ± 467 ns
MAPSE (mm) 16.4± 01.1 15.4± 1.2 ns
HR: heart rate, bpm: best per minute, CVP: central venous pressure, LA: left atrium, RA: right atrium, TOE: transoesophageal echocardiography, MAPSE:
mitral annulus systolic excursion, cm2: squared centimetres, mm: millimeters, and mL/min: milliliters per minute.
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Figure 5: Line graphic of a patient with an episode of acute blood
loss, comparing the time of CVP, LA dimension, and visible LA area
changes. Note that the LA parameters changed earlier than CVP.
dependent variables, a significant association was found be-
tween CVP and RA area (P = 0.001), but not between CVP
and LA dimension (P = 0.07).
In 5 patients a comparison of the CO by TEE and
PiCCO was possible, consisting in 39 paired simultaneous
measurements. In Figure 6 the linear correlation is presented;
the P value is <0.001, and the correlation coeﬃcient was 0.83
(Figure 6). The mean error between CO obtained by TOE
and PiCCO2 was 63.6 ± 528.2 (limits: −1722 to 1230).
4. Discussion
Data from this pilot study highlighted several possibilities of
TOE as an intraoperative monitoring tool for liver surgery.
It also brings some new data that would be subjected to
further studies and analyses. The hypotension episodes ob-
served tested the clinical utility of TOE monitoring. It could
eﬀectively detect changes in CO and detected changes in vol-
ume status earlier than comparative pressure-derived meth-
ods, along with the LV function monitoring.
The assessment of volume status is a major concern for
any surgery. CVP monitoring was the “standard” method
used. The comparative analysis of invasive and noninvasive
parameters revealed some new data. In most cases of acute
volume loss, as seen in major haemorrhage, LA dimensions
changes were observed earlier, by 10 to 15 minutes, which
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Figure 6: Dispersion graphic comparing the cardiac output ob-
tained by PiCCO2 and TEE (P < 0.001, r = 0.83).
may be considered an early adaptive phenomenon in order to
ensure LV filling pressure (during volume loss the decrease in
LA dimension prevents further decrease in LA pressure and
consequent LV filling pressure). Interestingly, the same chan-
ges were observed during liver manipulation, which results in
decreased preload due to vascular compression. This infor-
mation is important and allows the anaesthesiologist to an-
ticipate adequate therapeutic actions. To our knowledge, this
finding has not yet been described in the literature. However,
RA area was the parameter with a statistically significant as-
sociation with CVP, not the LA dimension.
The present study evaluated preload not preload depen-
dency, using comparative data from static parameters.
Among the possible parameters, left ventricular end diastolic
area (LVEDA) could not be considered as transgastric views
were not obtained [9]. Dynamic concepts for fluid admin-
istration [10, 11] and preload dependency were not also
considered in the present study. Only when PiCCO system
was inserted could the anaesthesiologists evaluate the systolic
volume variation, and fluids were often administered when-
ever this parameter was >15%, regardless of haemodynamic
status. Several TOE parameters can be used to assess preload
dependency [12, 13], and in some settings they were used
to guide intraoperative fluid administration. In this regard
we must consider that the protocol was formulated in order
to detect and characterize acute changes, not to guide fluid
administration. The emphasis was acute volume loss mainly
blood losses that should be rapidly treated. In other words,
we focused on acute phenomena.
CO has gained particular attention as a way of accessing
the global circulatory status, but how accurately this variable
measures the adequacy of circulatory flow is yet to be estab-
lished. Perhaps the usefulness of CO consists in detecting
changes in this variable during surgery, especially during
episodes of instability. Considering this as the main use of
CO monitoring, the changes are more important than its
absolute value. Using TEE, CO was monitored through the
mitral pulsed-Doppler influx, an occasionally used method
[14, 15]. In this method mitral valve annulus was used as
a surrogate for cross-sectional area. The accuracy of mitral
valve stroke volume is debatable. Themitral valve orifice does
not have a perfect geometrical shape; thus it is not used by
investigators. As we decided not to use intragastric views in
order not to interfere with surgery, this was the possible, non-
time-consuming method. The correlation obtained with the
PiCCO system was statistically significant (P < 0.001), with
r value of 0.83. Although the methods are diﬀerent the
importance of this parameter is its changes during acute
events, and in this regard both methods were reliable,
although TOE-derived CO presented greater variability than
PiCCO-derived CO.
Left ventricular function was monitored through mitral
valve annular plane systolic excursion, a method widely used
and tested [16, 17]. The LV function monitoring ability
is perhaps one of the most important features of TOE
monitoring. No other means is comparable not even the
classic methods. It was a valuable tool in the approach of
hypotension in one patient, guiding inotropic and vasopres-
sor support and detecting a transient LV dysfunction in other
3 episodes of hypotension. This detection was only possible
because TOE monitoring was present, and we could not
detect a cause for this phenomenon. Also, we could not find a
similar description in the literature. Although an experienced
observer could detect changes in LV function subjectively,
MAPSE was used in this pilot study as an objective measure-
ment. One should remember that LV systolic dysfunction can
also be easily detected by simultaneous changes in mitral VTI
and MAPSE.
Other possibilities of TOE were not observed in this
study, for example, the detection of right heart overload and
alterations in cardiac chambers, mainly due to gas embolism
or thrombus formation. In a larger cohort study they could
possibly be observed.
5. Study Limitations
In this pilot study the preload determination was considered
rather than preload dependency. The invasive counterpart
for preload dependency estimation can be the systolic vol-
ume variation, and several TOE parameters can be used to
evaluate, such as the analysis of superior vena cava, an easy
procedure to carry out during TOE examination. This need
was not particularly expressed by anaesthesiologists, more
focused on acute and life-threatening phenomena and LV
function. But in future protocols this item can be used. Some
other measurements could be considered but, as we limited
the information to a non-time-consuming acquisition in
order to describe an easy-to-use tool during anaesthesia,
most information was limited. More complex data can be
obtained through this technique which, yet due to time
constraints typical of an operating theatre, went beyond the
scope of this study.
In the future it is also necessary to enrol patients who
present atrial fibrillation, in order to fully understand the
limitations of TOE monitoring.
Another question regards TOE possibilities. Right heart
dysfunction and/or overload could not be detected in the
patients studied, but it can be an advantage in the use of TOE.
Other conditions resulting from the cardiac imaging (valvu-
lar regurgitations, intracardiac masses or thrombi) can also
present an advantage, not observed in the studied patients.
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6. Conclusion
The use of a TOE monitoring was possible during liver sur-
gery, in order to assess volume status, LV function, and CO.
In five patients monitored with the PiCCO system, a statisti-
cally significant correlation between CO obtained by mitral
valve VTI was obtained. TOE was also useful during episodes
of hypotension, detecting changes in volume status earlier
than invasive tools.
TOE is a possible and valuable tool in monitoring liver
surgery, and its use by anaesthesiologists should be encour-
aged. More data is needed to establish its role in other non-
cardiac surgery monitoring.
References
[1] E. Catena and D. Mele, “Role of intraoperative transesophag-
eal echocardiography in patients undergoing noncardiac sur-
gery,” Journal of Cardiovascular Medicine, vol. 9, no. 10, pp.
993–1003, 2008.
[2] M. Minhaj, K. Patel, D. Muzic et al., “The eﬀect of routine in-
traoperative transesophageal echocardiography on surgical
management,” Journal of Cardiothoracic and Vascular Anesthe-
sia, vol. 21, no. 6, pp. 800–804, 2007.
[3] N. Kolev, R. Brase, J. Swanevelder et al., “The influence of
transoesophageal echocardiography on intra-operative deci-
sion making. A European multicentre study. European Peri-
operative TOE Research Group,” Anaesthesia, vol. 53, pp. 767–
773, 1998.
[4] A. A. Klein, A. Snell, S. A. M. Nashef, R. M. O. Hall, J.
D. Kneeshaw, and J. E. Arrowsmith, “The impact of intra-
operative transoesophageal echocardiography on cardiac sur-
gical practice,” Anaesthesia, vol. 64, no. 9, pp. 947–952, 2009.
[5] D. C. Oxorn, “Intraoperative echocardiography,” Heart, vol.
94, no. 9, pp. 1236–1243, 2008.
[6] Y. Ozier and J. R. Klinck, “Anesthetic management of hepatic
transplantation,” Current Opinion in Anaesthesiology, vol. 21,
no. 3, pp. 391–400, 2008.
[7] A. J. Burtenshaw and J. L. Isaac, “The role of tras-esophageal
echocardiography for perioperative cardiovascular monitor-
ing during orthotopic liver transplantation,” Liver transplan-
tation, vol. 12, pp. 1577–1583, 2006.
[8] D. B. Wax, A. Torres, C. Scher, and A. B. Leibowitz, “Trans-
esophageal echocardiography utilization in high-volume liver
transplantation centers in the United States,” Journal of
Cardiothoracic and Vascular Anesthesia, vol. 22, no. 6, pp. 811–
813, 2008.
[9] J. Renner, M. Gruenewald, P. Brand et al., “Global end-diastol-
ic volume as a variable of fluid responsiveness during acute
changing loading conditions,” Journal of Cardiothoracic and
Vascular Anesthesia, vol. 21, no. 5, pp. 650–654, 2007.
[10] P. E. Marik, R. Cavallazzi, T. Vasu, and A. Hirani, “Dynamic
changes in arterial waveform derived variables and fluid
responsiveness in mechanically ventilated patients: a system-
atic review of the literature,” Critical Care Medicine, vol. 37,
no. 9, pp. 2642–2647, 2009.
[11] B. Tavernier, O. Makhotine, G. Lebuﬀe, J. Dupont, and P.
Scherpereel, “Systolic pressure variation as a guide to fluid
therapy in patients with sepsis-induced hypotension,” Anes-
thesiology, vol. 89, no. 6, pp. 1313–1321, 1998.
[12] N. G. Goddard, L. T.Menadue, andH. G.Wakeling, “A case for
routine oesophageal Doppler fluid monitoring during major
surgery becoming a standard of care,” British Journal of Anaes-
thesia, vol. 99, no. 4, p. 599, 2007.
[13] T. D. Phan, H. Ismail, A. G. Heriot, and K. M. Ho, “Im-
proving perioperative outcomes: fluid optimization with the
esophageal doppler monitor, a metaanalysis and review,” Jour-
nal of the American College of Surgeons, vol. 207, no. 6, pp. 935–
941, 2008.
[14] W. E. Miller, K. L. Richards, and M. H. Crawford, “Accuracy
of mitral Doppler echocardiographic cardiac output determi-
nations in adults,” American Heart Journal, vol. 119, no. 4, pp.
905–910, 1990.
[15] P. Nissen, J. J. Van Lieshout, S. Novovic, M. Bundgaard-
Nielsen, and N. H. Secher, “Techniques of cardiac output mea-
surement during liver transplantation: arterial pulse wave ver-
sus thermodilution,” Liver Transplantation, vol. 15, no. 3, pp.
287–291, 2009.
[16] Y. Cevik,M. Degertekin, Y. Basaran, F. Turan, andO. Pektas, “A
new echocardiographic formula to calculate ejection fraction
by using systolic excursion of mitral annulus,” Angiology, vol.
46, no. 2, pp. 157–163, 1995.
[17] M. F. Elnoamany and A. K. Abdelhameed, “Mitral annular
motion as a surrogate for left ventricular function: correlation
with brain natriuretic peptide levels,” European Journal of
Echocardiography, vol. 7, no. 3, pp. 187–198, 2006.
